Fischer Financial Services’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.83M Sell
20,157
-5
-0% -$859 0.96% 29
2026
Q1
$3.4M Sell
20,162
-159
-0.8% -$27.2K 1.15% 25
2025
Q4
$3.43M Sell
20,321
-149
-0.7% -$24.2K 0.91% 28
2025
Q3
$2.96M Sell
20,470
-456
-2% -$62.2K 0.8% 30
2025
Q2
$2.65M Sell
20,926
-682
-3% -$83.7K 0.78% 30
2025
Q1
$2.76M Buy
21,608
+125
+0.6% +$16.9K 0.89% 31
2024
Q4
$2.84M Buy
+21,483
New +$3.02M 0.89% 29

Other funds holding IBB

Fischer Financial Services's IBB Position: Q2 2026 in Review

Fischer Financial Services reduced its iShares Biotechnology ETF (IBB) stake by 0.02% in Q2 2026, selling an estimated $859 and leaving 20,157 shares worth $3.83M. The position accounts for 0.96% of the portfolio, ranked #29.

Fischer Financial Services first reported a position in IBB in Q4 2024 and has held it in 7 quarters since. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Fischer Financial Services held 20,157 shares of iShares Biotechnology ETF worth $3.83M as of Q2 2026.
  • Fischer Financial Services sold 5 iShares Biotechnology ETF shares in Q2 2026, an estimated $859.
  • iShares Biotechnology ETF made up 0.96% of Fischer Financial Services's portfolio in Q2 2026, its #29 holding.
  • Fischer Financial Services first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 7 quarters since.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Fischer Financial Services's 13F filing for Q2 2026, filed 11 Aug 2026.